Institutional Ownership
Abvc Biopharma Inc
CUSIP 00091F304COM NEWABVCQ1 2026
13D / 13G Filings
6
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
18.5%
Max % of class reported
Institutional Holders
11
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
6 filings · latest Aug 13, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 13, 2025 | Lind Global Fund II LP | 13G/A | 11.0% | 557.1K | SEC |
| 2 | Jul 15, 2025 | Eugene Jiang | 13D/A | 18.5% | — | SEC |
| 3 | Jun 3, 2025 | Eugene Jiang | 13D | 17.4% | — | SEC |
| 4 | Feb 14, 2025 | Lind Global Fund II LP | 13G/A | 11.0% | 1.32M | SEC |
| 5 | Nov 14, 2024 | Lind Global Fund II LP | 13G/A | 9.9% | 1.15M | SEC |
| 6 | Feb 13, 2024 | Lind Global Fund II LP | 13G/A | 9.9% | 770.0K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 221.2K | $214.6K |
| 2 | Renaissance Technologies LLC | 95.1K | $92.3K |
| 3 | State Street Corp | 72.8K | $70.6K |
| 4 | Blackrock, Inc. | 56.4K | $54.8K |
| 5 | Northern Trust Corp | 32.1K | $31.1K |
| 6 | Two Sigma Securities, LLC | 21.0K | $20.4K |
| 7 | Dimensional Fund Advisors LP | 12.2K | $11.9K |
| 8 | Squarepoint Ops LLC | 10.5K | $10.2K |
| 9 | Tower Research Capital LLC (Trc) | 5.4K | $5.3K |
| 10 | Ubs Group AG | 1.8K | $1.7K |